A group of women who took a contraceptive injection called Depo-Provera are suing the pharmaceutical giant Pfizer after ...

Medroxyprogesterone acetate 150mg/mL; IM inj. Medroxyprogesterone acetate inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation and causes thickening of ...

The FDA approved a label change for Pfizer’s birth control injection Depo-Provera on Dec. 13, adding a warning about the risk of meningioma — a brain tumor — to two versions of the drug. The update ...

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that ...

A woman in the United Kingdom experienced a side effect of eye protrusion after receiving contraceptive injections for 20 ...

If you have questions about filing a Depo-Provera lawsuit, you are not alone. As awareness of the link between Depo-Provera and intracranial meningioma continues to grow, we are continuing to hear ...

For decades, Depo-Provera has been presented as a game-changing contraceptive—a quick injection every three months that promised simplicity and effectiveness. For millions of women worldwide, it ...

Teva Pharmaceutical Industries Ltd., TEVA announced the reintroduction of the generic equivalent to Depo-Prover Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP) 150 ...

Obese women who take long-term birth control injection Depo-Provera may be at greater risk for developing diabetes, according to a new USC study. Researchers at the Keck School of Medicine found that ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...